Related Experiment Video
Updated: May 20, 2026
12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Incorporating a diabetes certificate program in a pharmacy curriculum.
James Sterrett1, Meg Croom, Cynthia M Phillips
1South Carolina College of Pharmacy, MUSC Campus, Charleston, USA.
American Journal of Pharmaceutical Education
|July 5, 2012
Summary
Integrating a diabetes certificate program into pharmacy school improved student competency and confidence in diabetes care. Students were highly satisfied with the curriculum, demonstrating preparedness for pharmaceutical care.
Area of Science:
- Pharmacy Education
- Diabetes Management
- Curriculum Development
Background:
- Doctor of Pharmacy (PharmD) programs require robust training in chronic disease management.
- Diabetes care necessitates specialized knowledge and practical skills for pharmacists.
Purpose of the Study:
- To assess student competency and confidence in diabetes care.
- To evaluate student satisfaction with the integration of a diabetes certificate program into the PharmD curriculum.
Main Methods:
- Longitudinal incorporation of the American Pharmacist Association/American Association of Diabetes Educators (APhA/AADE) diabetes certificate program into third-year skills laboratory courses.
- Utilized diverse educational techniques including self-study, lectures, case studies, modeling, role-playing, standardized patient exercises, and a diabetes simulation.
Main Results:
- Students achieved a 100% pass rate on the certificate examination.
- High student confidence in providing diabetes care (mean scores 4.2-4.8) and program satisfaction (mean scores 4.5-4.8) were reported.
- Students scored a mean of 71.8/100 on a medication therapy management (MTM) objective structured clinical examination (OSCE).
Conclusions:
- Longitudinal integration of a recognized diabetes certificate program enhances PharmD curricula.
- The program successfully produced competent and satisfied students prepared for diabetes pharmaceutical care.
Related Concept Videos
01:15Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
01:22Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
01:25Insulin: Biosynthesis, Chemistry, and Preparation
The endoplasmic reticulum (ER) of pancreatic β-cells synthesizes preproinsulin, which consists of a signal peptide, A and B chains, and a C-peptide. Preproinsulin is then cleaved and folded into proinsulin, which translocates to the Golgi apparatus for sorting and packaging into secretory granules. In these granules, enzymatic clipping generates insulin and C-peptide.
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment primarily uses...
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment primarily uses...
01:26Diabetes Mellitus: Introduction
Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...
01:28Dosage Regimens: Designs and Approaches
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...